Johan Frieling

561 total citations
20 papers, 447 citations indexed

About

Johan Frieling is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Johan Frieling has authored 20 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Johan Frieling's work include Blood Coagulation and Thrombosis Mechanisms (9 papers), Immune Response and Inflammation (7 papers) and Hemophilia Treatment and Research (6 papers). Johan Frieling is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (9 papers), Immune Response and Inflammation (7 papers) and Hemophilia Treatment and Research (6 papers). Johan Frieling collaborates with scholars based in Netherlands, United States and United Kingdom. Johan Frieling's co-authors include Robert W. Sauerwein, John Wijdenes, Nico Karssemeijer, Jan H. C. L. Hendriks, Cees J. van der Linden, Josje van der Linden, Marcel van Deuren, J.A. van der Vliet, J.W.M. van der Meer and R. J. A. Goris and has published in prestigious journals such as Blood, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Johan Frieling

20 papers receiving 431 citations

Peers

Johan Frieling
Brian B. Chesebro United States
PM Jansen Netherlands
Yoshinobu Fuke Japan
Mario Veitl Austria
Ingrid Stroo Netherlands
Timothy J. Fischer United States
Androniki Bili United States
Hiromasa Harada Japan
Dario Bongiovanni Germany
Zeyu Xiong United States
Brian B. Chesebro United States
Johan Frieling
Citations per year, relative to Johan Frieling Johan Frieling (= 1×) peers Brian B. Chesebro

Countries citing papers authored by Johan Frieling

Since Specialization
Citations

This map shows the geographic impact of Johan Frieling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Frieling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Frieling more than expected).

Fields of papers citing papers by Johan Frieling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Frieling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Frieling. The network helps show where Johan Frieling may publish in the future.

Co-authorship network of co-authors of Johan Frieling

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Frieling. A scholar is included among the top collaborators of Johan Frieling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Frieling. Johan Frieling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ducore, Jonathan M., Jeanne B. Lawrence, Mindy Simpson, et al.. (2017). Safety and dose‐dependency of eptacog beta (activated) in a dose escalation study of non‐bleeding congenital haemophilia A or B patients, with or without inhibitors. Haemophilia. 23(6). 844–851. 13 indexed citations
2.
Lawrence, Jeffry B., Jacobus Burggraaf, Jonathan M. Ducore, et al.. (2016). A Phase Ib, Dose Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Coagulation Factor VIIa in Congenital Hemophilia A or B. 22. 68–68. 1 indexed citations
3.
Triche, Elizabeth W., Allison James, Maria T. DeSancho, et al.. (2015). Recombinant Human Antithrombin in Pregnant Patients with Hereditary Antithrombin Deficiency: Integrated Analysis of Clinical Data. American Journal of Perinatology. 33(4). 343–349. 14 indexed citations
4.
Frieling, Johan, Jasper Stevens, Joannes A. A. Reijers, et al.. (2015). Populationpharmacokinetic/pharmacodynamic modeling of a new recombinant human factor VIIA (LR769) to derive the dose to be studied in phase 3. University of Groningen research database (University of Groningen / Centre for Information Technology). 13. 966–966. 1 indexed citations
5.
Paidas, Michael J., Cecily Forsyth, I. Quéré, et al.. (2014). Perioperative and peripartum prevention of venous thromboembolism in patients with hereditary antithrombin deficiency using recombinant antithrombin therapy. Blood Coagulation & Fibrinolysis. 25(5). 444–450. 14 indexed citations
6.
Ornaghi, Sara, Kurt T. Barnhart, Johan Frieling, James B. Streisand, & Michael J. Paidas. (2014). Clinical syndromes associated with acquired antithrombin deficiency via microvascular leakage and the related risk of thrombosis. Thrombosis Research. 133(6). 972–984. 24 indexed citations
7.
DeJongh, Joost, et al.. (2013). Pharmacokinetics of Recombinant Human Antithrombin in Delivery and Surgery Patients With Hereditary Antithrombin Deficiency. Clinical and Applied Thrombosis/Hemostasis. 20(4). 355–364. 5 indexed citations
8.
9.
Tait, Robert C., Don W. Shaffer, F. Baudo, et al.. (2008). Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations. Thrombosis and Haemostasis. 99(3). 616–622. 27 indexed citations
10.
Tait, Robert C. & Johan Frieling. (2008). Antithrombin Alfa in Hereditary Antithrombin Deficient Patients at High Risk for Thromboembolic Complications. Blood. 112(11). 986–986. 2 indexed citations
11.
Frieling, Johan, Carol A. Ziomek, Lynn Peters, et al.. (2007). No Immunogenicity Found to Antithrombin alfa in Human Clinical Studies.. Blood. 110(11). 3197–3197. 1 indexed citations
12.
13.
Frieling, Johan, Henk W. van Hamersvelt, John Wijdenes, et al.. (1999). Circulating Concentrations of Soluble Interleukin 6 Receptors gp80 and gp130 in Chronic Renal Failure and Effects ofRenal Replacement Therapy. American Journal of Nephrology. 19(5). 571–575. 9 indexed citations
14.
Deuren, Marcel van, Johan Frieling, Johanna van der Ven‐Jongekrijg, et al.. (1998). Plasma Patterns of Tumor Necrosis Factor‐α (TNF) and TNF Soluble Receptors During Acute Meningococcal Infections and the Effect of Plasma Exchange. Clinical Infectious Diseases. 26(4). 918–923. 24 indexed citations
15.
Frieling, Johan, et al.. (1997). Differential induction of pro- and anti-inflammatory cytokines in whole blood by bacteria: effects of antibiotic treatment. Antimicrobial Agents and Chemotherapy. 41(7). 1439–1443. 47 indexed citations
16.
Frieling, Johan, Marcel van Deuren, John Wijdenes, et al.. (1996). Interleukin-6 and its soluble receptor during acute meningococcal infections. Critical Care Medicine. 24(11). 1801–1805. 17 indexed citations
17.
Frieling, Johan, Marcel van Deuren, John Wijdenes, et al.. (1995). Circulating Interleukin-6 Receptor in Patients with Sepsis Syndrome. The Journal of Infectious Diseases. 171(2). 469–472. 60 indexed citations
18.
Frieling, Johan, et al.. (1994). Soluble interleukin 6 receptor in biological fluids from human origin. Cytokine. 6(4). 376–381. 58 indexed citations
19.
Karssemeijer, Nico, Johan Frieling, & Jan H. C. L. Hendriks. (1993). Spatial Resolution in Digital Mammography. Investigative Radiology. 28(5). 413–419. 58 indexed citations
20.
Roumen, Rudi M. H., et al.. (1993). Endotoxemia after major vascular operations. Journal of Vascular Surgery. 18(5). 853–857. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian B. Chesebro Breakdown of academic impact, for papers by PM Jansen Breakdown of academic impact, for papers by Yoshinobu Fuke Breakdown of academic impact, for papers by Mario Veitl Breakdown of academic impact, for papers by Ingrid Stroo Breakdown of academic impact, for papers by Timothy J. Fischer Breakdown of academic impact, for papers by Androniki Bili Breakdown of academic impact, for papers by Hiromasa Harada Breakdown of academic impact, for papers by Dario Bongiovanni Breakdown of academic impact, for papers by Zeyu Xiong
Rankless by CCL
2026